Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:15372107  

PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance.

Rohit N Kulkarni | Ulupi S Jhala | Jonathon N Winnay | Stan Krajewski | Marc Montminy | C Ronald Kahn
The Journal of clinical investigation | 2004

Inadequate compensatory beta cell hyperplasia in insulin-resistant states triggers the development of overt diabetes. The mechanisms that underlie this crucial adaptive response are not fully defined. Here we show that the compensatory islet-growth response to insulin resistance in 2 models--insulin receptor (IR)/IR substrate-1 (IRS-1) double heterozygous mice and liver-specific IR KO (LIRKO) mice--is severely restricted by PDX-1 heterozygosity. Six-month-old IR/IRS-1 and LIRKO mice both showed up to a 10-fold increase in beta cell mass, which involved epithelial-to-mesenchymal transition. In both models, superimposition of PDX-1 haploinsufficiency upon the background of insulin resistance completely abrogated the adaptive islet hyperplastic response, and instead the beta cells showed apoptosis resulting in premature death of the mice. This study shows that, in postdevelopmental states of beta cell growth, PDX-1 is a critical regulator of beta cell replication and is required for the compensatory response to insulin resistance.

Pubmed ID: 15372107

Associated grants

  • Agency: NIDDK NIH HHS, United States
    Id: U19 DK042502
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK 67536
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK 36836
  • Agency: NIDDK NIH HHS, United States
    Id: DK 02885
  • Agency: NIDDK NIH HHS, United States
    Id: U19 DK 42502
  • Agency: NIDDK NIH HHS, United States
    Id: K08 DK002885
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK036836
  • Agency: NIDDK NIH HHS, United States
    Id: R56 DK067536
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK067536

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Joslin Diabetes Center Bioinformatics and Biostatistics Core (tool)

RRID:SCR_015092

Core that offers support for data-driven projects related to basic, clinical and translational research, with a particular emphasis on diabetes. The core aims to ensure that researchers take advantage of the most modern and robust methods available in the field of Bioinformatics and Biostatistics.

View all literature mentions

Joslin Diabetes Center Flow Cytometry Core Facility (tool)

RRID:SCR_009878

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 27,2023. Core that provides cell sorting and flow cytometry services. Specific services include cell analysis, large object sorting,magnetic cell enrichment, and automatic cell counting.

View all literature mentions

Joslin Diabetes Center Advanced Microscopy Core Facility (tool)

RRID:SCR_009875

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 27,2023. Core that provides services for performing specific morphological procedures, providing training and access to equipment, maintaining the specialized microscopes, and giving advice and interpretation.

View all literature mentions

Joslin Diabetes Center Animal Physiology Core Facility (tool)

RRID:SCR_009876

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 27,2023. Core that provides technically advanced physiological evaluation of metabolism in diabetes, obesity, and their associated complications in rodents for DRC investigators and outside users. It also provides training of investigators and trainees in several physiological procedures.

View all literature mentions

Joslin Diabetes Center Advanced Genomics and Genetics Core Facility (tool)

RRID:SCR_009873

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 27,2023. Core that provides services for genetic and genomic analysis, including DNA extraction from blood, access to DNA collections from the Core?s repository, SNP genotyping, and support for gene expression studies based on both high-density oligonucleotide arrays and real-time quantitative PCR.

View all literature mentions

Joslin Diabetes Center Induced Pluripotent Stem Cell Core (tool)

RRID:SCR_015120

Core that maintains a centralized facility for the generation and propagation of reprogrammed iPS cells for use in molecular and cellular pathologies underlying diabetes and its complications.

View all literature mentions

Joslin Diabetes Center Enrichment Core (tool)

RRID:SCR_015094

Six component core which facilitates the exchange of research information and discussions among investigators, fellows and students within the Joslin Diabetes Center, as well as between Joslin Staff and outside researchers with similar interests.

View all literature mentions